{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:23:30Z","timestamp":1761863010945,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1124\/jpet.111.179747","type":"journal-article","created":{"date-parts":[[2011,4,2]],"date-time":"2011-04-02T03:52:56Z","timestamp":1301716376000},"page":"220-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents"],"prefix":"10.1016","volume":"338","author":[{"given":"Hiroshi","family":"Nagabukuro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Alexandra","family":"Wickham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison A.","family":"Kulick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loise","family":"Gichuru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcie J.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory O.","family":"Voronin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary P.","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher V.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2005","series-title":"Urodynamics","author":"Abrams","key":"10.1124\/jpet.111.179747_bib1"},{"key":"10.1124\/jpet.111.179747_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int"},{"key":"10.1124\/jpet.111.179747_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.eururo.2008.01.007","article-title":"Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects","volume":"53","author":"Amend","year":"2008","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.111.179747_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0302-2838(02)00540-7","article-title":"Antimuscarinics and the overactive detrusor\u2013which is the main mechanism of action?","volume":"43","author":"Andersson","year":"2003","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.111.179747_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2210-5-14","article-title":"Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions","volume":"5","author":"Angelico","year":"2005","journal-title":"BMC Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/jpet.111.179747_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0090-4295(02)01803-4","article-title":"Muscarinic receptor subtypes and management of the overactive bladder","volume":"5","author":"Chapple","year":"2002","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2680.2001.00231.x","article-title":"The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro","volume":"21","author":"Chess-Williams","year":"2001","journal-title":"J Auton Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-410X.1985.tb06358.x","article-title":"Bladder electromyograms and function in monkeys after atropine","volume":"57","author":"Craggs","year":"1985","journal-title":"Br J Urol"},{"key":"10.1124\/jpet.111.179747_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-4295(97)00587-6","article-title":"A neurologic basis for the overactive bladder","volume":"50","author":"de Groat","year":"1997","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib11","series-title":"The Autonomic Nervous System. Nervous Control of the Urogenital System","first-page":"227","article-title":"Neurophysiology of micturition and its modification in animal models of human disease","author":"de Groat","year":"1993"},{"key":"10.1124\/jpet.111.179747_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.20208","article-title":"Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics","volume":"25","author":"De Laet","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.111.179747_bib13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.ju.0000049903.60057.4b","article-title":"Intravesical oxybutynin: a local anesthetic effect on bladder C afferents","volume":"169","author":"De Wachter","year":"2003","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-5347(01)66007-5","article-title":"Effects of anesthesia on urodynamic studies in the primate model","volume":"156","author":"Ghoniem","year":"1996","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.108.143495","article-title":"The role of melanin-concentrating hormone-1 receptors in the voiding reflex in rats","volume":"328","author":"Hegde","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179747_bib16","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1038\/sj.bjp.0706560","article-title":"Muscarinic receptors in the bladder: from basic research to therapeutics","volume":"147","author":"Hegde","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.bjp.0701048","article-title":"Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo","volume":"120","author":"Hegde","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0024-3205(98)00581-5","article-title":"Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder","volume":"64","author":"Hegde","year":"1999","journal-title":"Life Sci"},{"year":"1996","series-title":"Guide for the Care and Use of Laboratory Animals","key":"10.1124\/jpet.111.179747_bib19"},{"key":"10.1124\/jpet.111.179747_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02201987","article-title":"Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group","volume":"15","author":"Jonas","year":"1997","journal-title":"World J Urol"},{"key":"10.1124\/jpet.111.179747_bib21","first-page":"189","article-title":"Effect of the anticholinergic drug with calcium antagonistic activity, (+\/\u2212)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in rhesus monkeys","volume":"47","author":"Kimura","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.111.179747_bib22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.urology.2004.11.021","article-title":"Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways","volume":"65","author":"Kim","year":"2005","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-5347(05)00004-2","article-title":"Central muscarinic receptor subtypes regulating voiding in rats","volume":"175","author":"Kono","year":"2006","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib24","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/j.1476-5381.1995.tb15065.x","article-title":"Characterization of the functional muscarinic receptors in the rat urinary bladder","volume":"116","author":"Longhurst","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1124\/jpet.108.145508","article-title":"Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa","volume":"328","author":"Mansfield","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.179747_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.urology.2009.12.013","article-title":"Differential roles of M2 and M3 muscarinic receptor subtypes in modulation of bladder afferent activity in rats","volume":"75","author":"Matsumoto","year":"2010","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0090-4295(02)01535-2","article-title":"Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats","volume":"59","author":"Modiri","year":"2002","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5347(06)00563-5","article-title":"Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations","volume":"176","author":"Mukerji","year":"2006","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.autneu.2010.02.006","article-title":"Correlation between pharmacologically-induced changes in cystometric parameters and spinal c-Fos expression in rats","volume":"156","author":"Nagabukuro","year":"2010","journal-title":"Auton Neurosci"},{"key":"10.1124\/jpet.111.179747_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1248\/bpb.30.54","article-title":"Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents","volume":"30","author":"Ohtake","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.111.179747_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1442-2042.1997.tb00215.x","article-title":"Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency","volume":"4","author":"Sasaki","year":"1997","journal-title":"Int J Urol"},{"key":"10.1124\/jpet.111.179747_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-5347(17)37193-8","article-title":"Effect of time interval and overdistension on repeated urodynamic studies","volume":"147","author":"Shoukry","year":"1992","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1476-5381.2010.00752.x","article-title":"AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder","volume":"160","author":"Sinha","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tips.2010.07.004","article-title":"Recent advances in the development of antimuscarinic agents for overactive bladder","volume":"31","author":"Smith","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.111.179747_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/nau.1930140606","article-title":"Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity","volume":"14","author":"Stahl","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"10.1124\/jpet.111.179747_bib36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000282207","article-title":"Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial","volume":"47","author":"Stohrer","year":"1991","journal-title":"Urol Int"},{"key":"10.1124\/jpet.111.179747_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2005.02.023","article-title":"Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats","volume":"512","author":"Suzuki","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.179747_bib38","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.juro.2007.06.044","article-title":"Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure","volume":"178","author":"Yokoyama","year":"2007","journal-title":"J Urol"},{"key":"10.1124\/jpet.111.179747_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.urology.2005.08.014","article-title":"Non-neuronal cholinergic system in human bladder urothelium","volume":"67","author":"Yoshida","year":"2006","journal-title":"Urology"},{"key":"10.1124\/jpet.111.179747_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1254\/jphs.09R12FM","article-title":"The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder","volume":"112","author":"Yoshida","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/jpet.111.179747_bib41","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/nau.20487","article-title":"Lower urinary tract symptoms (LUTS) and bladder afferent activity","volume":"26","author":"Yoshimura","year":"2007","journal-title":"Neurourol Urodyn"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.179747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:32:00Z","timestamp":1740018720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524464422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022356524464422"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.179747","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Analysis of the Effects of Antimuscarinic Agents on Bladder Functions in Both Nonhuman Primates and Rodents","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.179747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}